1. Home
  2. SILO vs STSS Comparison

SILO vs STSS Comparison

Compare SILO & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$0.51

Market Cap

4.6M

ML Signal

HOLD

Logo Sharps Technology Inc.

STSS

Sharps Technology Inc.

HOLD

Current Price

$1.56

Market Cap

43.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SILO
STSS
Founded
2010
2017
Country
United States
United States
Employees
N/A
55
Industry
Apparel
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
43.8M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
SILO
STSS
Price
$0.51
$1.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
179.0K
331.3K
Earning Date
05-08-2026
04-06-2026
Dividend Yield
N/A
N/A
EPS Growth
57.98
N/A
EPS
N/A
N/A
Revenue
$72,102.00
N/A
Revenue This Year
$1.86
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.01
52 Week High
$1.18
$18.23

Technical Indicators

Market Signals
Indicator
SILO
STSS
Relative Strength Index (RSI) 76.02 39.79
Support Level $0.30 $1.42
Resistance Level $0.64 $2.02
Average True Range (ATR) 0.04 0.11
MACD 0.01 -0.02
Stochastic Oscillator 70.87 27.66

Price Performance

Historical Comparison
SILO
STSS

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About STSS Sharps Technology Inc.

Sharps Technology Inc is a medical device and pharmaceutical packaging company offering patented, smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities that incorporate syringe technologies that use both passive and active safety features. The Company has adopted a digital asset treasury scheme focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the Solana Ecosystem.

Share on Social Networks: